~~<i id='A8C83478F8'><strike id='A8C83478F8'><tt id='A8C83478F8'><pre id='A8C83478F8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

knowledge

author：explore 2025-09-30 14:08:04 - browse：4

Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： FTX founder Sam Bankman

focus

hotspot

focus

hotspot

1:40SashaPaskal,a7-year-oldUkrainiangymnastwholostaleginaRussianmissilestrike,isseeninundatedphotoss

WSS

Former Georgia lieutenant governor says he received grand jury subpoena

It's time to take a new tack for treating Alzheimer's

Why the advice to take all your antibiotics may be wrong

Hey, doctors: Don't be no

Pfizer's RSV vaccine recommended for approval in Europe

Biden White House, tech companies launch new safeguards around emerging AI technology

hotspot

knowledge

focus

ChatGPT in medicine: STAT answers readers' burning questions

Hospitals use virtual reality to design more inclusive rooms for kids

What does generative AI mean for health care? We asked experts

Germany receives 178 compensation applications from gay servicepeople over discrimination

Peter Hotez and the public health issue of online harassment

Sage's campaign to raise awareness of postpartum depression hits a nerve

Supreme Court strikes down use of affirmative action

Hospitals use virtual reality to design more inclusive rooms for kids

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New chief aims to remake Sanofi Genzyme

focus

Hey, doctors: Don't be no

Biden praises World Series champion Astros for impact off the field during White House celebration

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Astronauts get first look at the spacecraft that will fly them around the moon

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

CDC launches VaccineFinder tool to locate Covid

hotspot

focus

hotspot

hotspot